Terms: = Germ cell tumor AND GRIN2A, Q12879, 2903, ENSG00000183454, NMDAR2A, NR2A
24 results:
1. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
Zhang H; Chen W; Li Z; Huang Q; Wen J; Chang S; Pei H; Ma L; Li H
J Ethnopharmacol; 2024 Jan; 318(Pt B):116985. PubMed ID: 37532075
[TBL] [Abstract] [Full Text] [Related]
2. RNA Sequencing of Intraoperative Peritumoral Tissues Reveals Potential Pathways Involved in Glioma-Related Seizures.
Kumar K; Dubey V; Zaidi SS; Tripathi M; Siraj F; Sharma MC; Chandra PS; Doddamani R; Dixit AB; Banerjee J
J Mol Neurosci; 2023 Jun; 73(6):437-447. PubMed ID: 37268865
[TBL] [Abstract] [Full Text] [Related]
3. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
Zou Q; Zhang L; Cheng Z; Guo X; Cao D
Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
[TBL] [Abstract] [Full Text] [Related]
4. Co-expression of NMDA-receptor subunits NR1, nr2a, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
[TBL] [Abstract] [Full Text] [Related]
5. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
Zhang D; Xia J
BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
[TBL] [Abstract] [Full Text] [Related]
6. Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma.
Georgescu MM; Olar A
Acta Neuropathol Commun; 2020 Feb; 8(1):10. PubMed ID: 32014051
[TBL] [Abstract] [Full Text] [Related]
7. Genetic and Functional Analysis of grin2a in tumor Samples.
Prickett TD; Gartner JJ; Samuels Y
Methods Mol Biol; 2017; 1677():93-116. PubMed ID: 28986867
[TBL] [Abstract] [Full Text] [Related]
8. MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.
Rinner B; Gandolfi G; Meditz K; Frisch MT; Wagner K; Ciarrocchi A; Torricelli F; Koivuniemi R; Niklander J; Liegl-Atzwanger B; Lohberger B; Heitzer E; Ghaffari-Tabrizi-Wizsy N; Zweytick D; Zalaudek I
Sci Rep; 2017 May; 7(1):2098. PubMed ID: 28522871
[TBL] [Abstract] [Full Text] [Related]
9. Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; de Juan Jimenez I; Escutia Muñoz B; Rodríguez Serna M; Alegre de Miquel V; Llavador Ros M; Ballester Sánchez R; Nagore Enguídanos E; Palanca Suela S; Botella Estrada R
Sci Rep; 2017 Mar; 7(1):495. PubMed ID: 28356599
[TBL] [Abstract] [Full Text] [Related]
10. Selected grin2a mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate.
D'mello SA; Joseph WR; Green TN; Leung EY; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
Cell Calcium; 2016 Dec; 60(6):384-395. PubMed ID: 27659111
[TBL] [Abstract] [Full Text] [Related]
11. [Identification of NMDA receptor in normal bovine ovary and ovum].
Tachibana N; Ikeda S
Rinsho Shinkeigaku; 2014; 54(12):1031-3. PubMed ID: 25672700
[TBL] [Abstract] [Full Text] [Related]
12. The genetic basis of new treatment modalities in melanoma.
Kunz M
Curr Drug Targets; 2015; 16(3):233-48. PubMed ID: 25654738
[TBL] [Abstract] [Full Text] [Related]
13. Somatic mutation of grin2a in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.
Prickett TD; Zerlanko BJ; Hill VK; Gartner JJ; Qutob N; Jiang J; Simaan M; Wunderlich J; Gutkind JS; Rosenberg SA; Samuels Y
J Invest Dermatol; 2014 Sep; 134(9):2390-2398. PubMed ID: 24739903
[TBL] [Abstract] [Full Text] [Related]
14. Oncogenes in melanoma: an update.
Kunz M
Eur J Cell Biol; 2014; 93(1-2):1-10. PubMed ID: 24468268
[TBL] [Abstract] [Full Text] [Related]
15. [Melanoma: from molecular studies to the treatment breakthrough].
Imianitov EN
Arkh Patol; 2013; 75(5):63-72. PubMed ID: 24341237
[TBL] [Abstract] [Full Text] [Related]
16. Exome sequencing identifies grin2a as frequently mutated in melanoma.
Wei X; Walia V; Lin JC; Teer JK; Prickett TD; Gartner J; Davis S; ; Stemke-Hale K; Davies MA; Gershenwald JE; Robinson W; Robinson S; Rosenberg SA; Samuels Y
Nat Genet; 2011 May; 43(5):442-6. PubMed ID: 21499247
[TBL] [Abstract] [Full Text] [Related]
17. Xenon blocks AMPA and NMDA receptor channels by different mechanisms.
Weigt HU; Fohr KJ; Georgieff M; Georgieff EM; Senftleben U; Adolph O
Acta Neurobiol Exp (Wars); 2009; 69(4):429-40. PubMed ID: 20048760
[TBL] [Abstract] [Full Text] [Related]
18. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract] [Full Text] [Related]
19. Coupling of energy metabolism and synaptic transmission at the transcriptional level: role of nuclear respiratory factor 1 in regulating both cytochrome c oxidase and NMDA glutamate receptor subunit genes.
Dhar SS; Wong-Riley MT
J Neurosci; 2009 Jan; 29(2):483-92. PubMed ID: 19144849
[TBL] [Abstract] [Full Text] [Related]
20. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.
Dalmau J; Tüzün E; Wu HY; Masjuan J; Rossi JE; Voloschin A; Baehring JM; Shimazaki H; Koide R; King D; Mason W; Sansing LH; Dichter MA; Rosenfeld MR; Lynch DR
Ann Neurol; 2007 Jan; 61(1):25-36. PubMed ID: 17262855
[TBL] [Abstract] [Full Text] [Related]
[Next]
